BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25052561)

  • 1. Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity.
    Bishop AJ; Greenfield B; Mahajan A; Paulino AC; Okcu MF; Allen PK; Chintagumpala M; Kahalley LS; McAleer MF; McGovern SL; Whitehead WE; Grosshans DR
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):354-61. PubMed ID: 25052561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative analysis of craniopharyngioma cyst expansion during and after radiation therapy and surgical implications.
    Lamiman K; Wong KK; Tamrazi B; Nosrati JD; Olch A; Chang EL; Kiehna EN
    Neurosurg Focus; 2016 Dec; 41(6):E15. PubMed ID: 27903114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma.
    Greenfield BJ; Okcu MF; Baxter PA; Chintagumpala M; Teh BS; Dauser RC; Su J; Desai SS; Paulino AC
    Radiother Oncol; 2015 Feb; 114(2):224-9. PubMed ID: 25542650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent craniopharyngioma after conformal radiation in children and the burden of treatment.
    Klimo P; Venable GT; Boop FA; Merchant TE
    J Neurosurg Pediatr; 2015 May; 15(5):499-505. PubMed ID: 25700121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting.
    Santos PMG; Barsky AR; Hwang WT; Deville C; Wang X; Both S; Bekelman JE; Christodouleas JP; Vapiwala N
    Cancer; 2019 Dec; 125(23):4278-4293. PubMed ID: 31503338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes following proton therapy for adult craniopharyngioma: a single-institution cohort study.
    Rutenberg MS; Rotondo RL; Rao D; Holtzman AL; Indelicato DJ; Huh S; Morris CG; Mendenhall WM
    J Neurooncol; 2020 Apr; 147(2):387-395. PubMed ID: 32086697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis.
    Xi M; Xu C; Liao Z; Chang JY; Gomez DR; Jeter M; Cox JD; Komaki R; Mehran R; Blum MA; Hofstetter WL; Maru DM; Bhutani MS; Lee JH; Weston B; Ajani JA; Lin SH
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):667-676. PubMed ID: 29280461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis.
    Dutz A; Agolli L; Baumann M; Troost EGC; Krause M; Hölscher T; Löck S
    Acta Oncol; 2019 Jun; 58(6):916-925. PubMed ID: 30882264
    [No Abstract]   [Full Text] [Related]  

  • 9. A Model-Based Approach to Predict Short-Term Toxicity Benefits With Proton Therapy for Oropharyngeal Cancer.
    Rwigema JM; Langendijk JA; Paul van der Laan H; Lukens JN; Swisher-McClure SD; Lin A
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):553-562. PubMed ID: 30625409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pooled patient-reported outcomes analysis of moderately hypofractionated proton beam therapy and photon-based intensity modulated radiation therapy for low- or intermediate-risk prostate cancer.
    Lukez A; Handorf E; Mendenhall NP; Henderson RH; Stish BJ; Davis BJ; Hallman M; Horwitz EM; Vapiwala N; Wong JK
    Prostate; 2024 Mar; 84(4):395-402. PubMed ID: 38108113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer.
    Lin SH; Hobbs BP; Verma V; Tidwell RS; Smith GL; Lei X; Corsini EM; Mok I; Wei X; Yao L; Wang X; Komaki RU; Chang JY; Chun SG; Jeter MD; Swisher SG; Ajani JA; Blum-Murphy M; Vaporciyan AA; Mehran RJ; Koong AC; Gandhi SJ; Hofstetter WL; Hong TS; Delaney TF; Liao Z; Mohan R
    J Clin Oncol; 2020 May; 38(14):1569-1579. PubMed ID: 32160096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
    Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
    Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
    Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
    Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure Risks Among Children Undergoing Radiation Therapy: Considerations in the Era of Image Guided Radiation Therapy.
    Hess CB; Thompson HM; Benedict SH; Seibert JA; Wong K; Vaughan AT; Chen AM
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):978-92. PubMed ID: 27026304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the benefits and risks of proton therapy in pediatric craniopharyngioma.
    Beltran C; Roca M; Merchant TE
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e281-7. PubMed ID: 21570209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton Radiation Therapy for Pediatric Craniopharyngioma.
    Jimenez RB; Ahmed S; Johnson A; Thomas H; Depauw N; Horick N; Tansky J; Evans CL; Pulsifer M; Ebb D; Butler WE; Fullerton B; Tarbell NJ; Yock TI; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1480-1487. PubMed ID: 33662460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy.
    Sato M; Gunther JR; Mahajan A; Jo E; Paulino AC; Adesina AM; Jones JY; Ketonen LM; Su JM; Okcu MF; Khatua S; Dauser RC; Whitehead WE; Weinberg J; Chintagumpala MM
    Cancer; 2017 Jul; 123(13):2570-2578. PubMed ID: 28267208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities.
    Parikh RR; Rhome R; Hug E; Tsai H; Cahlon O; Chon B; Goenka A
    Clin Lung Cancer; 2016 Sep; 17(5):362-366. PubMed ID: 27372386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer.
    Fang P; Mick R; Deville C; Both S; Bekelman JE; Christodouleas JP; Guzzo TJ; Tochner Z; Hahn SM; Vapiwala N
    Cancer; 2015 Apr; 121(7):1118-27. PubMed ID: 25423899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of multimodal surgical and radiation treatment methods for pediatric craniopharyngioma: long-term analysis of progression-free survival and morbidity.
    Ravindra VM; Okcu MF; Ruggieri L; Frank TS; Paulino AC; McGovern SL; Horne VE; Dauser RC; Whitehead WE; Aldave G
    J Neurosurg Pediatr; 2021 May; 28(2):152-159. PubMed ID: 34049281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.